Haemonetics Corporation announced that its President and CEO, Chris Simon, will be participating in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026, at 10:25 a.m. ET. A live webcast will be available on the company’s Investor Relations website, with a replay accessible for 90 days following the event. Haemonetics is a global medical technology company focused on improving healthcare quality and efficiency through various innovative solutions.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
Haemonetics Corporation announced that its President and CEO, Chris Simon, will be participating in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026, at 10:25 a.m. ET. A live webcast will be available on the company’s Investor Relations website, with a replay accessible for 90 days following the event. Haemonetics is a global medical technology company focused on improving healthcare quality and efficiency through various innovative solutions.